2339 results
Article
We respond to new figures from Cancer Research UK showing thousands fewer breast cancer patients started treatment in the last year in England
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said:
Article
We respond to the latest COVID-19 guidance
Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said:
Article
A potential new way to overcome fulvestrant resistance in secondary breast cancer
Scientists have furthered our understanding of how some secondary breast cancers can become resistant to the hormone therapy fulvestrant.
Drug
Leuprorelin (Prostap)
Leuprorelin, also known as Prostap, is a hormone therapy used to treat breast cancer in women who've not been through the menopause.
Personal Story
Walking saved me after I lost my mum
When Sacha lost her mum to breast cancer in 2019, she wanted to do something in her memory.
Drug
Paclitaxel (Taxol)
Learn about chemotherapy drug paclitaxel (Taxol), including when it's used and its side effects.
Event
Overnight events
Article
We respond to NICE provisional decision to not recommend elacestrant in England
Claire Rowney, chief executive at Breast Cancer Now, said:
Article
Breast Cancer Now response to the death of Linda Nolan
Claire Rowney, CEO, Breast Cancer Now says:
Article
We respond to publication of Scottish Referral Guidelines for Suspected Cancer
Melanie Sturtevant, associate director of policy, evidence and influencing at Breast Cancer Now, said:
Event
